UK Digital Pathology Market will experience a noticeable growth during the forecast period 2019-2025

UK digital pathology market is expected to grow at a CAGR of approximately 14.2% during the forecast period. Increasing UK government focus towards digital pathology is encouraging the demand of digital pathology in the region. For instance, in 2017, Leica Biosystem and UK Office of Life Sciences entered into agreement to support the UK mission to advance AI in pathology.

Request a Free Sample of our Report on UK Digital Pathology Market: https://www.omrglobal.com/request-sample/uk-digital-pathology-market

The healthcare providers, including NHS trust polymouth hospitals, Derriford hospital are in demand of digital pathology for research and training purpose, which is further encouraging the UK digital pathology market growth. Moreover, CM-Path (National Cancer Research Institute (NCRI)) has taken initiative for reinvigorate academic pathology in the UK. This will provide scope for wider and faster implementation of digital pathology for patient's benefit. Additionally, there is scope of the current molecular diagnostic and digital pathology attitudes and provisions across the UK.

The significant investment by 25 organizations from across the sector and supported by government will ensure the UK is at the forefront of developing new innovative treatments and medical technologies that will improve patient's life. Various laboratories in the UK have already implemented or are about to implement digital pathology techniques by using whole slide imaging, having evaluated the balance of risks and benefits for the work of their laboratories. This enables to drive the UK digital pathology.

Regulations in the UK includes, For WSI devices, the instrument manufacturers are required to obtain regulatory approval before selling a device for diagnostic purpose. It undergoes with quality control of design and manufacturing that ensures the viability of the device. UK government are also taking steps to modernize the industry, expand the small businesses, which is expected to create significant opportunity for the market growth. The government has given the commitment to invest up to $351 million for diagnostics every year by 2020. Additionally, the national health service (NHS) in England announced to invest $17.5 million on the program for faster diagnosis of cancer. This involve funding for productive diagnostic services, trailing new multidisciplinary diagnostic centers and testing of new faster diagnosis standard.

A Full Report of UK Digital Pathology Market is Available at https://www.omrglobal.com/industry-reports/uk-digital-pathology-market

UK Digital Pathology Market Segmentation

By-Products and Services
o Diagnostic Devices
o Scanners and Microscope
o Communication Platform
o Storage
o Others

By End-User
o Biotechnology and Pharmaceutical Companies
o Diagnostic Centers
o Academics Centers

By Applications
o Anatomical Pathology
o Chemical Pathology
o Forensic Pathology
o Clinical Pathology
o Immunopathology Pathology
o Others

Company Profiles
o Apollo Pacs Inc.
o Aurora Interactive Ltd.
o BARCO
o Carl Zeiss AG
o Digipath Inc.
o Leica Microsystems GmbH
o Ligolab LLC
o micro dimensions GmbH
o Mikroscan Technologies Inc.
o Nikon Instruments Inc.
o Olympus Corp.
o Philips Healthcare

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/uk-digital-pathology-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.